Heartwatch: the effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profiles
- 1 May 2010
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 18 (1) , 129-135
Abstract
Heartwatch is a secondary prevention programme of coronary heart disease (CHD) in primary care in Ireland. The aim was to further examine the effect of the Heartwatch programme on cardiovascular risk factors and treatments of patients with a follow-up of 3.5 years. Prospective cohort study of 12,358 patients with established CHD (myocardial infarction, percutaneous cardiac intervention, coronary artery bypass graft) recruited by participating general practitioners; patients invited to attend on a quarterly basis, with continuing care implemented according to defined clinical protocols. Changes in risk factors and treatments at 1, 2, 3 and 3.5-year follow-up from baseline were made using paired t-test for continuous and McNemar's test for categorical data. Important changes in systolic and diastolic blood pressure, total and low-density lipoprotein cholesterol and smoking status were observed at 1, 2, 3 and 3.5 years (P < 0.0001) with significant increase in proportions of patients within the target. However, changes in body mass index were small, with no significant improvement in waist circumference. There was a significant increase in prescription of secondary preventive medications and good patient compliance. Males were more likely to be within the target for systolic blood pressure, total cholesterol, waist circumference and exercise level at 3.5 years, but less likely for body mass index. Studies of cardiac rehabilitation without any follow-up programmes show that over time patients revert in part to previous lifestyle habits; this primary care-delivered programme has shown sustained improvements in major risk factors, particularly smoking, blood pressure and cholesterol, and treatments for CHD. Weight management presents a greater challenge.Keywords
This publication has 20 references indexed in Scilit:
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEuropean Journal of Preventive Cardiology, 2009
- Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesThe Lancet, 2009
- Heartwatch: a secondary prevention programme in primary care in IrelandEuropean Journal of Preventive Cardiology, 2008
- Long term adherence to dietary recommendations after inpatient rehabilitation: prospective follow up study of patients with coronary heart diseaseHeart, 2006
- Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000Journal of Epidemiology and Community Health, 2006
- Effectiveness of Statin Therapy in Adults With Coronary Heart DiseaseArchives of internal medicine (1960), 2004
- Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trialsThe American Journal of Medicine, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort studyEuropean Heart Journal, 2001
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2Atherosclerosis, 1998